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Abstract 
 
The need for software is increasingly growing in the 
medical device industry. Even though the primary 
concern of medical device software development is safety, 
medical device software development organisations are 
also concerned with time and budget overruns, plus 
ensuring that the customer requirements are fulfilled. At 
present the medical device software industry lacks 
strategies to combine adhering to mandatory regulatory 
guidelines with increasing the quality of the software 
developed. Software process improvement (SPI) assists 
software development organizations to increase their 
software quality, and assessments are an integral part of 
this process. Unfortunately, software process assessments 
are often expensive and time consuming. Additionally, 
they often provide companies with a long list of issues 
without providing realistic suggestions. The goal of this 
paper is to describe the implementation of a new low-
overhead hybrid assessment method that has been 
designed specifically for medical device software 
development organisations wishing to improve their 
software development practices. This assessment method 
combines the SPI models of the Capability Maturity 
Model Integration (CMMI) and ISO/IEC 15504-5 with 
medical device software development regulations.  
 
1. Introduction 
 
Due to the safety-critical nature of the medical devices, 
organizations developing  medical device software are 
expected to produce high-quality software through the use 
of defined processes.  
Medical device companies must comply with the 
regulatory requirements of the countries in which they 
wish to sell their devices. Compliance requirements 
stipulate that the manufacturers must produce a design 
history file detailing the software components and 
processes undertaken in the development of their medical 
devices. Due to the safety-critical nature of medical 
device software it is important that highly effective 
software development practices are in place within 
medical device companies.  Although guidance exists 
from regulatory bodies on what software activities must be 
performed, no specific method for performing these 
activities is outlined or enforced.  
To tackle these issues, governments have put in place 
regulatory bodies whose job it is to define regulatory 
systems for medical devices and to ensure that only safe 
medical devices are placed on the market.  A safe device 
is one which cannot cause serious injury to a patient or 
end-user of the device.  
Medical device companies must comply with the 
medical device regulations stipulated by regulatory bodies 
governing the country in which they to wish to market 
their device.  The medical device companies must be able 
to produce sufficient evidence to support their claims of 
compliance.  To this end, in the USA, the Center for 
Devices and Radiological Health (CDRH) has published 
guidance papers which include risk-based activities to be 
performed during software validation [1], pre-market 
submission [2] and when using off-the-shelf software in a 
medical device [3].  Although the CDRH guidance 
documents provide information on which software 
activities should be performed, they do not enforce any 
specific method for performing these activities.  Much of 
the guidance provided is ambiguous and does not provide 
details on how software activities should be performed.  
This information is spread across various regulatory 
guidance papers, industry guidance papers, standards and 
technical implementation reports. The obvious implication 
of this is that medical device manufacturers could fail to 
comply with the expected requirements. 
Within the medical device industry a decision was 
made to recognise the ISO/IEC 12207 [4] software 
engineering standard for general medical device software 
development.  However, the Association for the 
Advancement of Medical Instrumentation (AAMI) 
software committee carefully reviewed the ISO/IEC 
12207 standard and decided it was necessary to create a 
new standard specifically for medical device software 
development.  This was due to a number of gaps in the 
existing standard in relation to medical device software 
regulations.  For example, the existing ISO/IEC 12207 
standard required major changes for those companies who 
already had existing software processes in place and did 
not account for off-the-shelf (OTS) software requirements.   
However, the AAMI did not discard the work done 
with the ISO/IEC 12207 standard and instead used it as 
the foundation for their new standard “AAMI SW68, 
Medical device software – Software lifecycle processes”.  
AAMI SW68 [5] defines two major lifecycle processes 
i.e. - a development process and a maintenance process.  
The SW68 standard was produced with both application 
software and embedded software in mind.  Where a 
medical device comprises software or is used in 
conjunction with software, the standard considers the 
software to be a sub-system of the medical device itself. In 
2006, a new standard AAMI/IEC 62304 [6] was released 
that was based on the AAMI SW68 standard. 
Whenever we mention medical device guidelines 
within this paper we refer to the following medical device 
standards and guidelines: ANSI/AAMI/IEC 62304, FDA 
[1,2,3,7], European Council Guidelines [8], ISO 14971 
[9], EN 60601-1-4 [10], TIR 32 [11], GAMP 5 [12], 
AAMI/IEC 61508 [13] and IEC 60812  [14].  
 
2. SPI Models 
 
SPI initiatives can be based on various models such as 
the Capability Maturity Model Integration (CMMI) [15] 
or process standards such as ISO 15504-5 [16] and ISO 
9001 [17, 18]. Implementation of changes identified 
during SPI assessments enable organizations to reduce 
software development costs [17,18, 19]. For example, 400 
projects reported increased productivity as a result of 
implementing CMMI based improvement programmes 
[19]. This study reported a 12% reduction in software 
product development times and a 49% reduction in 
defects through using CMM/CMMI based improvement 
programmes. However, many companies are reluctant to 
adopt the assessment part of these models as they feel that 
they are too cumbersome and expensive for small 
organisations [20].  
The first step in engaging in SPI is to assess the current 
state of an organization’s  software development practices. 
A SPI path may be developed based upon a combination 
of this starting point and the business goals of the 
organisation [21].  Processes in small organisations must 
be catered for in a different manner than within large 
companies [22] as existing SPI assessment methods are 
very cumbersome and are not suited to the needs of small 
organisations. Consequently, small companies need 
specialized assessment methods as they do not have the 
same resources to invest in SPI as large organisations. 
However, they require high quality software and efficient 
software development [23].  
Organizational maturity indicators like CMMI levels, 
ISO/IEC 15504 ratings or specific ISO standards have 
become important for software development. Customer 
organisations often rely on them when selecting a supplier 
as the results of these assessments can serve as an 
indicator of process maturity.  
This paper presents how a lightweight software process 
assessment method (Med-Adept) has been developed for 
the medical device software industry.  This method has 
been specifically developed to provide a low cost way of 
providing: 
 Non-medical device software development 
organisations with an assessment of how their existing 
software development practices will be required to 
change in order to become medical device software 
suppliers.  
 Existing medical device software development 
organisations with an assessment of how effective their 
existing software development practices are in relation 
to developing high quality software and adhering to 
medical device regulations  
The Med-Adept method integrates processes from 
CMMI and ISO/IEC 15504-5 with practices specified in 
medical device regulatory guidelines and standards.  
 
3. The Need for Med-Adept 
 
One of the main goals of the Regulated Software 
Research Group in Dundalk Institute of Technology is to 
support the growth of a medical device software 
development industry within Ireland. The Adept method 
[21] was previously developed to provide a light-weight 
assessment of software processes from CMMI and 
ISO/IEC 15504-5. The Adept method has now been 
integrated with practices specified in medical device 
regulatory guidelines and standards to produce Med-
Adept. Med-Adept is an assessment method that provides 
a means of assessing the software engineering capability 
for processes in relation to medical device software (both 
application and embedded software). 
Med-Adept enables software development 
organisations to gain an appreciation of the fundamental 
processes from CMMI, ISO/IEC 15504-5 and AAMI/IEC 
62304 (including additional practices required by other 
medical device guidelines and standards) through 
diagnosing strengths and weaknesses in their software 
development practices. Med-Adept was designed to 
adhere to 8 of the 10 criteria outlined by Anacleto et al. 
[24], for the development of lightweight assessment 
methods: low cost, detailed description of the assessment 
process, guidance for process selection, detailed definition 
of the assessment model, support for identification of risks 
and improvement suggestions, conformity with ISO/IEC 
15504, no specific software engineering knowledge 
required from companies’ representatives, and tool 
support is provided. The two exceptions to the criteria 
outlined Anacleto et al. [24], are that no support is 
provided for high-level process modeling and only the 
authors currently have access to method. Med-Adept also 
inherits the following requirements from Adept: 
improvement is more important than certification, a rating 
is not required, preparation time required by the company 
is minimised; assessment time is minimized, and 
companies should be enabled to select assessment in 
process areas that are most relevant to their business 
goals. 
While the main aims of Med-Adept are to either 
encourage non-medical device software development 
organisations to develop software for the medical device 
industry or to improve the software development 
processes within existing medical device software 
development organizations. Additionally, the Med-Adept 
method provides an ideal opportunity to educate software 
development organisations in terms of generic SPI.  
Therefore, the assessment would not be pointless if a non-
medical device software development company did not 
become a medical device software development company 
in the future. Consequently, Med-Adept provides medical 
device specific and non-medical device specific 
recommendations.  Assessed companies are also supplied 
with feedback in relation to both CMMI and ISO/IEC 
15504-5 which enables such companies to decide whether 
they wish to follow a CMMI or an ISO/IEC 15504-5 
improvement path. Med-Adept provides the assessed 
company with a findings document presented in terms of 
processes from CMMI, ISO/IEC 15504-5 and practices 
required by medical device software standards and 
regulations (with a particular focus on AAMI/IEC 62304).   
 
4. Development of the Med-Adept Method 
 
As Med-Adept is based upon the Adept method, 
existing Adept questions were used as the foundation for 
the Med-Adept method. Questions were added to enable 
coverage of medical device regulations. Even though each 
assessment component adopts a CMMI
 
process area name, 
it also contains questions providing coverage of relevant 
ISO/IEC 15504-5 processes and medical device standards 
and regulations (see table 1).  
 
Table 1 – Structure of Med-Adept 
Med- Adept Processes 
Adept Processes  
Selected CMMI 
Process Area 
Selected 
ISO/IEC 15504-5 
Process 
AAMI/IEC 62304 
Process 
Risk Management Risk Management Risk Management  
Configuration 
Management 
Configuration 
Management 
Configuration 
Management 
Requirements 
Management 
 
Requirements 
Development 
Requirements 
Elicitation 
Software 
Requirements 
Analysis  
Software 
Requirements 
Analysis 
Project Planning 
 
Project Monitoring 
& Control 
Project 
Management 
Software 
Development 
Planning 
 
Technical Solution 
 
Software Design 
Software 
Construction 
Software 
Architectural Design  
Software Detailed 
Design 
Product Integration Software 
Integration  
Software Integration 
Validation,  
Verification  
Software Testing 
Verification 
Validation 
Software Unit 
Implementation and 
Verification 
Integration Testing 
Software System 
Testing 
Process and Product 
Quality Assurance 
Quality 
Management 
System 
ISO 13485 
B.10 Quality 
Assurance 
Measurement and 
Analysis 
   
  
 
Software Release 
Software 
Maintenance  
 
Software Problem 
Resolution 
Documentation 
Software Safety 
Classification 
 
Table 1, illustrates that medical device regulatory 
questions are added for 11 of the 12 Adept processes, the 
exception being Measurement and Analysis which cannot 
be mapped against the processes of AAMI/IEC 62304. 
Additionally, the existing Adept processes (which Med-
Adept is founded upon) do not provide coverage of 5 
AAMI/IEC 62304 processes (Software Release, Software 
Maintenance, Software Problem Solution, Documentation, 
Software Safety Classification). Therefore, the pilot 
version of Med-Adept also does not provide coverage of 
these processes. Additionally, it should also be noted that 
pilot release of Med-Adept does not include the +SAFE 
[25] process areas that have been added as a safety 
extension to the CMMI model, or the safety extensions 
that will be released in 15504-10, or the Software Safety 
Classification process from AAMI/IEC 62304. 
Therefore in its current state Med-Adept will not 
provide complete coverage of all the medical device 
regulations and will need to be extended in the future to 
provide complete coverage. However, the main aim of 
Med-Adept is not to provide comprehensive coverage of 
medical device regulations, but rather to assist 
organisations to improve their software practices and to 
encourage organizations to develop medical device 
software. To encourage uptake of the Med-Adept 
assessment by software SMEs, on-site interviewing is 
restricted to one day [21] thus minimising the time and 
cost associated with the assessment.  
 
4.1. Scripted Med-Adept Questions 
 
Table 2 illustrates the breakdown of the scripted Med-
Adept questions. When developing the interview 
questions we examined the base practices, checking the 
relevant interview questions from the Adept method to 
ensure coverage of their counterparts in the medical 
device regulations.  There is some commonality between 
related processes in CMMI, ISO/IEC 15504-5 and 
AAMI/IEC 62304. However Med-Adept questions based 
solely upon a process within one model will not (in 
isolation) provide full coverage of this process within the 
other two models (this is illustrated in figure 1 for the risk 
management and configuration management processes).    
 
Table 2. Breakdown of Scripted Med-Adept Questions 
AHAA 
Interviews 
No. of Adept 
Questions 
No. of New 
Questions 
No. of Med-
Adept Questions 
Risk Management 
39 23 62 
Configuration 
Management 39 2 41 
 
 
 
 
 
4.2. Risk Management 
 
Within Adept 39 questions were used to provide 
coverage of the specific goals of the CMMI and the base 
practices of ISO/IEC 1504-5 for Risk Management. Med-
Adept is more comprehensive in its coverage of Risk 
Management and has 62 scripted questions for Risk 
Management (see Table 2). Med-Adept not only contains 
CMMI and ISO/IEC 15504-5 based questions but also 23 
additional questions that are specifically related to the 
Risk Management process of AAMI/IEC 62304 and other 
associated medical device standards and regulations.   
Figure 1, illustrates that out of the 33 scripted questions 
that are applicable to the CMMI model, 8 are applicable 
to both  ISO/IEC 15504-5 and medical device regulations, 
9 are applicable to ISO/IEC 15504-5, 17 are applicable 
from an medical device regulatory perspective, and 15 are 
only applicable to the CMMI model.  Out of the 46 
scripted questions that are applicable to the medical 
device regulations, 8 are applicable to both ISO/IEC 
15504-5 and CMMI, 6 are applicable to ISO/IEC 15504-
5, 9 are applicable from a CMMI perspective, and 23 are 
only applicable to the medical device regulations. Out of 
the 15 scripted questions that are applicable to the 
ISO/IEC 15504-5, 8 are applicable to both medical device 
regulations and CMMI, 14 are applicable to medical 
device regulations, 1 is applicable from a CMMI 
perspective, and none are only applicable to ISO/IEC 
15504-5.    
 
                          CMMI 
 
 
 
 
 
 
 
 
 
Figure 1. Breakdown of Risk Management 
Questions 
 
For example, establishing a risk management strategy 
is an important part of risk management. The Med-Adept 
method has 17 scripted questions that are asked to gain an 
understanding of the company’s procedure for 
establishing a risk management strategy for a project (see 
Table 3).  
9 
  
ISO/IEC 15504-5 
 
Medical Device Regulations  
 
8 
1 
23 
0 
15 
6 
These questions provide coverage of this topic in 
CMMI, ISO/IEC 15504 and the medical device 
regulations. Ten questions are asked which are only 
applicable in relation to medical device regulations. Two 
questions are asked that are based solely on the CMMI 
model and these are used to determine where the risk 
management strategy is documented and the tools that are 
used to support the risk management process. Two 
questions are applicable to CMMI, ISO/IEC 15504-5 and 
medical device regulations practices and these questions 
probe the existence of a risk management strategy and if 
this strategy covers different stages of a lifecycle model. 
Three questions are applicable to both ISO/IEC 15504-5 
and the medical device regulations. These questions are 
used to determine the scope of risk management within 
the organisations and whether it is at an organisational or 
a group level and to gain an understanding in relation to 
how risk is monitored. Configuration management 
questions were analysed in the same manner, providing a 
list of 41 scripted questions. 
 
4.3 Med-Adept Stages  
 
Med-Adept is composed of eight stages. The assessment 
team (normally) consists of two assessors who conduct the 
assessment between them.  
Stage 1 involves a preliminary meeting between the 
assessment team and the software company wishing to 
undergo a software process assessment.  The assessment 
team discuss the main drivers for the company embarking 
upon a Med-Adept assessment and establish whether the 
company is interested in developing software for the 
medical device industry. During stage 2 the lead assessor 
provides an overview of Med-Adept for members of the 
assessed organisation who will be involved in subsequent 
stages. This session is used to remove any concerns that 
individuals may have. 
 
Table 3. Med-Adept Questions for Establishing a 
risk management strategy 
 
Question CMMI ISO/IEC 
15504-5 
Medical 
Device 
Regulations  
Do you determine the scope of the 
risk management to be performed 
 Yes Yes 
Do you have a risk management 
strategy? - What kind of things does 
this include? 
Yes Yes Yes 
Do you include lifecycles phases for 
which the strategy is applicable ? 
Yes Yes Yes 
Do you use any tools to support risk 
management? 
Yes    
Where is the risk management 
strategy documented? 
Yes   
Do you define appropriate strategies 
and risk measures to identify, 
analyse, treat and monitor each risk 
or set of risks 
 Yes Yes 
Is this both at the project and 
organisational level.  
 Yes Yes 
Do you set acceptability levels for 
each risk or set of risks, both at the 
project and organizational level 
   Yes 
Do you include a verification plan 
as part of the strategy 
  Yes 
Do you outline the allocation of 
responsibilities 
  Yes 
Do you outline the requirements for 
reviewing the RM activities 
  Yes 
Do you analyse post-production 
queries and bugs  
  Yes 
Do you include at least one person 
in the RM activity that was involved 
in the software development, with 
both relevant medical device and 
RM knowledge along with the date 
of the analysis 
  Yes 
Is this person(s) identified on the 
report along with the date of the 
analysis 
  Yes 
Do you determine software hazards   Yes 
Does your RM strategy include Off-
The-Shelf Software as a potential 
hazard? 
  Yes 
Do you include hardware failures as 
a potential hazard 
  Yes 
 
Stage 3 provides a brief insight into project 
documentation. However, the primary source of data for 
Med-Adept is through a series of process interviews 
conducted during stage 4. In this stage key staff members 
from the assessed organisation are interviewed. There is 
an interview for each process. Each interview is scheduled 
to last approximately 1.5 hours. To enable stage 4 to be 
completed within 1 day we restrict the scope of a single 
Med-Adept assessment to 4 processes. Each interview 
(normally) involves two assessors and at least one 
representative from the company. Stage 5 is a 
collaborative exercise between the assessors to develop 
the findings report using interview notes for each of the 
assessed processes. The resultant findings report consists 
of a list of strengths, issues and suggested actions for each 
of the assessed processes.   
Stage 6 involves presenting the findings report to 
participating staff in the organisation. Stage 7 involves 
collaborating with staff to develop a roadmap.  This will 
provide guidance to the assessed company presenting 
practices that will provide the greatest benefit in terms of 
the company’s business goals. Companies wishing to 
develop software for the medical device industry are 
recommended to focus upon establishing working 
practices that will assist them to fulfil the medical device 
regulations. Stage 8 involves revisiting the assessed 
company approximately 3 to 6 months after the 
completion of stage 7 and reviewing progress against the 
SPI path. The outcome of this stage is an updated SPI path 
and a final report detailing the progress that has been 
accomplished along with additional recommendations. 
This stage provides feedback and assistance to the 
assessed company after a period of time and also assists in 
compiling research material in terms of SPI experiences.  
  
5. Med-Adept Implementation 
 
We implemented a Med-Adept assessment in the Irish 
site of a multinational medical device organization, 
MedSoft (a pseudonym). MedSoft did not develop 
electronic based medical devices but rather used software 
to control the manufacture of its medical devices. 
MedSoft wanted to understand their current software 
development practices and the extent to which these 
practices would have to change to comply with recent 
medical device standards such AAMI/IEC 62304. 
However, their primary interest was to determine if SPI 
practices could be introduced that would assist them to 
improve the efficiency and quality of their current risk 
management and configuration management practices. As 
this was a pilot assessment it was restricted to the 
processes of risk management and configuration 
management. MedSoft also sought a resource-light 
method to obtain guidance as to how they could improve 
these 2 processes. MedSoft was therefore an ideal 
candidate for a Med-Adept assessment. 
During stage 1 of the Med-Adept assessment the goals 
and schedule of the assessment were determined, 
involving an assessor (normally 2 assessors would 
participate in a Med-Adept assessment however as this 
was a pilot assessment involving only 2 processes and 2 
interviewees we decided that one assessor would be 
sufficient), a software development manager and a 
software engineer from MedSoft. It was discovered during 
stage 1 that the software development manager and the 
software engineer chosen to participate in the assessment 
both play pivotal roles in MedSoft’s risk management and 
configuration management processes. During stage 2 the 
assessor provided an overview briefing of Med-Adept to 
the software development manager and the software 
engineer. The assessor briefly inspected a sample risk 
management plan, sample minutes from project review 
meetings and a configuration management document 
(Stage 3). This enabled the assessor to gain a basic 
understanding of the documentation procedures within 
MedSoft, and also assisted the assessor to develop 
additional (MedSoft specific) questions for the process 
interviews.   
During stage 5 the assessor developed a findings 
report, listing strengths and issues for each of the 2 
assessed processes. This report also provided 
recommendations as to how to address the issues that were 
highlighted. The recommendations were also based on the 
business goals that were highlighted in stage 2. The main 
business goal that emerged was that more efficient risk 
management and configuration management regulatory 
complaint processes were desired. The findings report was 
then presented to the software development manager and 
the software engineer that participated in the Med-Adept 
assessment (stage 6). 
 
5.1 Risk Management Findings  
 
The Risk Management process interview contained 62 
scripted questions. Performance of the Med-Adept 
assessment method generated 11strengths, 24 issues and 
21 recommendations for the risk management process (see 
Table 4).  The action part of the table illustrates how 
suggestions (RMAct1-21) were provided to address each 
of the issues (RMIss1-24) that arose during the Med-
Adept assessment.  
 
Table 4.  Med-Adept Risk Management Findings 
Strength   Description of Strengths 
RMStr1 Patient risk is documented 
RMStr2  RM is documented as part of the company’s procedure 
RMStr3  RM is considered at the project level 
RMStr4 Ownership is assigned to Risks 
RMStr5 Acceptability levels are set for project risks 
RMStr6 The RM activity involves participants who are knowledgeable in 
software development and RM 
RMStr7 Risk documentation templates exist for Process, Patient and 
Technical Risk 
RMStr8 Risks are evaluated, categorised and prioritised on new systems 
RMStr9 Possible impact of risk is considered on new systems 
RMStr10  All RM activities are recorded for new systems 
RMStr11 Hardware failure is included as a potential hazard 
  
Issue No. Description of Issues 
RMIss1 No risk list of known risks held that can be used a starting point 
for analysing risks on new projects 
RMIss2 Assessment of risk likelihood depends on the experience of the 
team 
RMIss3 No thresholds are set to trigger management activities 
RMIss4 Thresholds are not set on risks for executing mitigation or 
contingency plans  
RMIss5 Acceptable risk levels not set for all risks 
RMIss6 No documented set of steps for reducing the likelihood and 
consequences of risk to an acceptable level 
RMIss7 No individual RM strategy –it  forms part of the overall 
procedures  
RMIss8 Project risk is not defined 
RMIss9 Risk is not defined by project 
RMIss10 Risk is not conducted at an organisational level 
RMIss11 Nothing documented in relation to assisting the  determination of 
hazards E.g. Off-the-shelf software is not defined as a potential 
hazard  
RMIss12 All elements of the WBS or project plan are not reviewed for 
risks on all projects 
RMIss13 No procedure for looking for new risk at any occurrence of 
technical or managerial decisions 
RMIss14 RM procedures are less efficient on old systems 
RMIss15 Recorded RM activities may be lost over time on old systems  
RMIss16 Low priority risks may be ignored 
RMIss17 RM is performed only at the initial stages of the project  
RMIss18 Do not continuously assess changes in the status of a risk 
RMIss19  No formal template exists for project risk 
RMIss20 Mitigation and Contingency Plans are not in place for all risks 
RMIss21 Mitigation and Contingency Plans that are in place are not 
verified 
RMIss22 Do not assess the effectiveness of risk treatment actions 
RMIss23 No timeline for risk handling activities 
RMIss24 Only highest priority risks are focused upon for mitigation and 
contingency 
  
Action 
No: 
Description of Actions 
RMAct1 Develop an Organisational RM Strategy 
RMAct2 Develop a Project RM Plan consisting of patient risk, technical 
risk, process risk. Consider hazards as part of this. E.g. Off-the-
Shelf Software, Hardware Failure, Environment 
RMAct3 Initiate the development of a risk list 
RMAct4 Risk list repository should be built containing sources of risk and 
hazards that may be referenced upon the commencement of a 
new project 
RMAct5 Risk list repository should contain previously encountered risks, 
common risks etc. 
RMAct6 Risk list repository should be split into categories as some risks 
may be more appropriate for particular types of projects 
RMAct7 Risk list repository should contain sample acceptability levels for 
each risk 
RMAct8 Risk list repository should contain sample steps for reducing the 
likelihood and consequence of particular risks 
RMAct9 Risk list repository should contain sample thresholds for 
executing mitigation or contingency plans  
RMAct10 Initiate the development of a formal template for identifying risks 
RMAct11  Include Context, Conditions and Consequences of the risk in the 
risk template 
RMAct12 Include both patient and project risk types in the template:  
RMAct13  When performing Risk Identification 
 Examine each part of the WBS or  project plan for risks 
 Use the risk list to help identify risks 
 Document the risk using the Risk Identification Template 
RMAct14 Analyse and Prioritise ALL Risks 
Evaluate the probability and the consequence of the occurrence 
of the risk 
RMAct15 Set threshold values for activating risk handling activities 
Use the records of similar risks in the risk list repository to assist 
with these steps 
RMAct16 Develop Risk Mitigation and Contingency Plans for ALL risks 
not just high priority ones 
RMAct17 Verify these Risk Mitigation and Contingency plans 
RMAct18 Perform RM activities throughout all stages of the project and 
not just at the initial stages 
RMAct19 Continuously monitor the status of risks 
RMAct20 Apply risk handling actions (if a risk exceeds an acceptability 
threshold) until the level of the risk is deemed acceptable 
RMAct21 Assess the effectiveness of risk handling actions and update the 
risk list repository with this information and improvements etc. 
 
Figure 2, provides a summary of MedSoft risk 
management practices within 7 practice areas. Each 
practice area consists of practices required by the CMMI, 
ISO/IEC 15504-5 and medical device regulations. Within 
figure 2, 0.0 indicates that a practice area is not performed 
whereas, 1.0 indicates that all sub-practices within a 
practice area are fully performed. The 7 practice areas are 
as follows: 
 Determine Risk Sources and Categories 
 Define Risk Parameters 
 Establish a Risk Management Strategy 
 Identify Risks 
 Evaluate, Categorise, and Prioritise Risks 
 Develop Risk Mitigation Plans 
 Implement Risk Mitigation Plans 
 
For example, table 3 demonstrates how establishing a 
risk management strategy area consists of 17 questions 
that provide coverage of this practice area within CMMI, 
ISO/IEC 15504-5 and the medical device regulations. 
Figure 2, illustrates that MedSoft appears quite strong in 
the practice areas of “Determining risk sources and 
categories”, “Establishing a risk management strategy” 
and “Evaluating, Categorising and prioritizing risks”. 
However, even these practice areas still require 
improvement and issues also arose within these areas. For 
example, even though a risk management strategy was 
established there was no procedure in place for identifying 
new risks at any occurrence of technical or managerial 
decisions within this strategy. The practice areas of 
“Defining risk parameters”, “Developing Mitigation 
Plans” and in particular “Implementing risk mitigation 
plans” were quite weak with a number of issues identified 
for these areas (see figure 2). Implementation of the 
suggested actions will improve each of the 7 practice 
areas, but in particular will greatly strengthen weaker 
practice areas such as “Implement risk mitigation plans”.    
 
 
 
Figure 2. Summary of the Med-Adept capability of 
the assessed risk management practices within 
MedSoft 
 
5.2 Summary of the Configuration Management 
Findings 
 
Upon assessment of the Configuration Management 
process within MedSoft using Med-Adept (largely based 
upon the 41 scripted questions) we discovered that 
Configuration Management was generally a well applied 
process in MedSoft (see figure 3). Most work products 
were tightly controlled, with both code and documentation 
being placed under configuration control using a tool that 
was developed internally within the organization. Well 
defined procedures were in place for the control, 
management, prioritisation and peer-review of change 
requests with evidence to suggest that the quality 
assurance team are quite successful at managing 
configuration issues. Additionally, an up-to-date 
description is kept of configuration items, with a log of 
change items being retrievable from the internal 
configuration management tool. Also, whenever a new 
baseline have been created this is published to the entire 
team.  
 
 
Figure 3. Summary of the Med-Adept capability of 
the assessed configuration management practices 
within MedSoft 
 
However, despite the fact that configuration 
management is performed well within MedSoft a number 
of issues were also highlighted and recommendations 
were provided to address these issues. Here are some 
examples: 
• Too much detail was defined in terms of change 
requests, particularly in the case of very small 
changes as the same level of detail was required for 
small changes as very large changes; 
• On average it took between 4 to 6 months for any 
change to be approved – even in the case of very 
small changes; 
• The configuration management system had a flat 
structure as opposed to a hierarchical one; 
• The internal configuration management  tool was 
used more for control than for management and 
other tools had to be used e.g. Gemini, SourceSafe, 
Sharepoint for management activities; 
• Some items that are not under configuration control 
were used in baselines. 
 
6. Summary and Conclusions 
 
Prior to this assessment MedSoft were not familiar 
with either AAMI/IEC 62304 or its predecessor SW68 
and whilst they had heard of CMMI and ISO/IEC 15504-5 
they had never engaged in implementing either of them.  
Upon analysis, the Med-Adept assessment revealed that 
MedSoft may be able to significantly improve their risk 
management development practices by adopting the 
recommendations suggested in the findings report through 
implementing the suggested practices. Additionally, even 
though MedSoft’s current configuration management 
processes are very strong in terms of control they could be 
improved in terms of management and the adoption of the 
suggestions recommended in the Med-Adept findings 
report would enable MedSoft to have both strong 
configuration and management practices. 
The MedSoft software development manager felt that 
the assessment was beneficial to the organisation in a 
number of respects. First, it provided MedSoft with 
knowledge and some high-level training in relation to 
CMMI and ISO/IEC 15504-5 practices for Risk 
Management and Configuration Management. Second, it 
provided MedSoft with an insight into the practices that 
are required by the medical device regulations in order to 
achieve compliance for these areas, and in particular it 
provided an introduction to the importance of the 
AAMI/IEC 62304 standard for the development of 
medical device software. Third, MedSoft liked the fact 
that the assessment required no preparation on their behalf 
and that very little time was required to perform the 
assessment. Fourth, MedSoft found it very useful to have 
an external audit of their configuration management and 
risk management processes so that issues could be 
highlighted and plans put in place to resolve these issues. 
Fifth, MedSoft recognised the importance of receiving 
external guidance in relation to improving their 
configuration management and risk management 
processes. 
During the findings presentation, the software 
development manager and the engineer both agreed that 
the highlighted strengths and issues were an accurate 
reflection of company’s risk management and 
configuration management practices. Both the 
management and developers of MedSoft acknowledged 
that the Med-Adept recommendations were achievable 
and if implemented could bring benefit.  
The software development manager from MedSoft also 
stated that they intended championing these improvements 
in the site the assessment was performed within and then 
rolling them out to other locations so that the overall 
organisation could benefit from incorporating the 
recommendations into their configuration management 
and risk management practices.  
Following the Med-Adept findings presentation, 
MedSoft representatives met internally to discuss 
developing a SPI path.  They reviewed and prioritised all 
the Med-Adept recommendations, planning how they will 
be implemented in a new project (stage 7 of Med-Adept).   
Having gone through this assessment cycle, 
management realised the importance of such assessments.  
Therefore, a criticism of the Med-Adept which they made 
was that they were only assessed in 2 processes. We have 
agreed to engage in an additional assessment involving 
other software processes (i.e. 2
nd
 release of Med-Adept). 
They also have requested that we re-assess their software 
processes within 6 months (perform stage 8 of the Med-
Adept) so that they may obtain feedback in relation to 
their progress along their SPI path. This will also provide 
the assessment team with an opportunity to validate their 
improvement suggestions. 
This paper presents how a Med-Adept assessment was 
conducted in a medical device software company. The 
company has since prioritised actions and are currently 
engaged in adopting a number of the recommendations as 
part of their software development practices.  It also 
describes a pilot release of the Med-Adept method, 
providing coverage of 2 processes. In the future we plan 
to extend the number of processes that may be assessed. 
We will extend the Med-Adept assessment to provide 
coverage of the remaining nine applicable processes that 
are displayed in table 1.  
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